BioVox Press Releases

• Published on February 26, 2025 - 07:00 GMT

  

  4Tissue secures an additional €1.5M in funding and appoints Dr. Katleen Verleysen as independent chair of the board.

  GHENT, BELGIUM, February 26, 2025 /⁨EINPresswire.com⁩/ -- 4Tissue, a pioneer in biotechnology that is revolutionizing regenerative medicine, has successfully completed an additional €1.5M funding round, consisting of €1M in equity investments and …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on January 15, 2025 - 11:00 GMT

  

  ONTOFORCE and Rancho Biosciences Collaborate to Leverage High Quality Data for Target Identification

  GHENT, BELGIUM, January 15, 2025 /⁨EINPresswire.com⁩/ -- Ghent, Belgium, 15 January 2025 – ONTOFORCE, a leader in semantic technology for life sciences, headquartered in Ghent, Belgium, and Rancho Biosciences, the leading data science services company …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 09:47 GMT

  

  miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific

  LEUVEN, BELGIUM, December 4, 2024 /⁨EINPresswire.com⁩/ -- miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry. …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 07:30 GMT

  

  European HealthTech Innovation Needs a Lifeline – Join the Conversation to Drive Change

  GHENT, BELGIUM, December 4, 2024 /⁨EINPresswire.com⁩/ -- European health technology (HealthTech) is at a critical crossroad. Despite groundbreaking research, a thriving startup scene and ambitious talent, the sector struggles to translate innovation into …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on December 4, 2024 - 07:00 GMT

  Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis

  Investment led by Boehringer Ingelheim Venture Fund, with the participation of new & existing investors, including Apollo Health Ventures, NRW.Venture, & HTGF. COLOGNE, GERMANY, December 4, 2024 /⁨EINPresswire.com⁩/ -- Refoxy Pharmaceuticals GmbH …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on October 23, 2024 - 06:00 GMT

  

  4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology

  GHENT, BELGIUM, October 23, 2024 /⁨EINPresswire.com⁩/ -- 4Tissue, a pioneering biotech company revolutionizing regenerative medicine with its cutting-edge, bioresorbable hydrogel tissue mimic has successfully completed a €2M seed funding round including …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on September 10, 2024 - 06:00 GMT

  ONTOFORCE unveils DISQOVER 7: the next generation knowledge discovery platform

  GHENT, BELGIUM, September 10, 2024 /⁨EINPresswire.com⁩/ -- ONTOFORCE, a leader in semantic technology for life sciences, announces the launch of DISQOVER 7, the most advanced version of its knowledge discovery platform. DISQOVER is designed to meet the …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on July 16, 2024 - 06:00 GMT

  

  ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust

  GHENT, BELGIUM, July 16, 2024 /⁨EINPresswire.com⁩/ -- ONTOFORCE, the provider of DISQOVER, a leading knowledge discovery platform for the life sciences industry, is pleased to announce that it has achieved the ISO 27001:2022 certification, a testament to …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on July 4, 2024 - 06:00 GMT

  

  Anacura acquires OHMX.bio, adding multi-omics for drug discovery and diagnostics to its services

  GHENT, BELGIUM, July 4, 2024 /⁨EINPresswire.com⁩/ -- Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology. The …

  Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...
• Published on March 12, 2024 - 08:04 GMT

  

  Azalea Vision Secures Prestigious European Innovation Council (EIC) Transition Grant

  Innovative Smart Contact Lens Developer Awarded €2.5M in Funding for Groundbreaking Ocular Health Technology GHENT, BELGIUM, March 12, 2024 /⁨EINPresswire.com⁩/ -- Azalea Vision, a pioneering developer of smart contact lens technology, is proud to …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...